業績

HOME > 業績
  • 原著 Early-phase prothrombin time-international normalized ratio in acute liver injury indicates the timing of therapeutic intervention and predicts prognostic improvement
    Kumagai K, Mawatari S, Moriuchi A, Oda K, Takikawa Y, Kato N, Oda S, Inoue K, Terai S, Genda T, Shimizu M, Sakaida I, Mochida S, Ido A.
    Hepatol Res. 2023 Feb;53(2):160-171. doi: 10.1111/hepr.13848. Epub 2022 Nov 10.
  • 原著 Navitoclax improves acute-on-chronic liver failure by eliminating senescent cells in mice
    Watanabe Y, Abe H, Kimura N, Arao Y, Ishikawa N, Yuichiro M, Setsu T, Sakamaki A, Kamimura H, Yokoo T, Kamimura K, Tsuchiya A, Terai S.
    Hepatol Res. 2023 Jan 11. doi: 10.1111/hepr.13879. Online ahead of print.
  • 原著 Analysis of drug-induced liver-related adverse event trend reporting between 1997 and 2019
    Kamimura H, Setsu T, Kimura N, Miyazawa M, Kaneko S, Kamimura K, Tsuchiya A, Uesawa Y, Terai S.
    Hepatol Res. 2023 Jan 20. doi: 10.1111/hepr.13883. Online ahead of print.
  • 原著 Cell-free and concentrated ascites reinfusion therapy versus large-volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study
    Hanai T, Kawaratani H, Nagano J, Suii H, Sakamaki A, Arase Y, Nakanishi H, Kogiso T, Okubo T, Miwa T, Shimizu S, Hige S, Atsukawa M, Shimizu M, Kurosaki M, Terai S, Kagawa T, Tokushige K, Yoshiji H.
    Hepatol Res. 2023 Mar;53(3):238-246. doi: 10.1111/hepr.13860. Epub 2022 Dec 3.
  • 原著 Analysis of distribution, collection, and confirmation of capacity dependency of small extracellular vesicles toward a therapy for liver cirrhosis
    Takeda N, Tsuchiya A, Mito M, Natsui K, Natusi Y, Koseki Y, Tomiyoshi K, Yamazaki F, Yoshida Y, Abe H, Sano M, Kido T, Yoshioka Y, Kikuta J, Itoh T, Nishimura K, Ishii M, Ochiya T, Miyajima A, Terai S.
    Inflamm Regen. 2023 Oct 9;43(1):48. doi: 10.1186/s41232-023-00299-x.
  • 原著 Analysis of Genetic Relatedness between Gastric and Oral Helicobacter pylori in Patients with Early Gastric Cancer Using Multilocus Sequence Typing
    Nagata R, Sato H, Takenaka S, Yokoyama J, Terai S, Mimuro H, Noiri Y.
    Int J Mol Sci. 2023 Jan 22;24(3):2211. doi: 10.3390/ijms24032211.
  • 原著 Basics, Epidemiology, Diagnosis, and Management of Liver Tumor
    Hiroyuki Abe, Kenya Kamimura
    J Clin Med. 2023 Jan 9;12(2):524. doi: 10.3390/jcm12020524.
  • 原著 Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey
    Nakase H, Wagatsuma K, Nojima M, Matsumoto T, Matsuura M, Iijima H, Matsuoka K, Ohmiya N, Ishihara S, Hirai F, Takeuchi K, Tamura S, Kinjo F, Ueno N, Naganuma M, Watanabe K, Moroi R, Nishimata N, Motoya S, Kurahara K, Takahashi S, Maemoto A, Sakuraba H, Saruta M, Tominaga K, Hisabe T, Tanaka H, Terai S, Hiraoka S, Takedomi H, Narimatsu K, Endo K, Nakamura M, Hisamatsu T.
    J Gastroenterol. 2023 Jan 6:1-12. doi: 10.1007/s00535-022-01949-6. Online ahead of print.
  • 原著 Letrozole ameliorates liver fibrosis through the inhibition of the CTGF pathway and 17β-hydroxysteroid dehydrogenase 13 expression
    Sakai N, Kamimura K, Miyamoto H, Ko M, Nagoya T, Setsu T, Sakamaki A, Yokoo T, Kamimura H, Soki H, Tokunaga A, Inamine T, Nakashima M, Enomoto H, Kousaka K, Tachiki H, Ohyama K, Terai S.
    J Gastroenterol. 2023 Jan;58(1):53-68. doi: 10.1007/s00535-022-01929-w. Epub 2022 Oct 27.
  • 原著 Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus
    Tahata Y, Hikita H, Mochida S, Enomoto N, Ido A, Kuroda H, Miki D, Kurosaki M, Hiasa Y, Sakamori R, Kawada N, Yamashita T, Suda G, Yatsuhashi H, Yoshiji H, Kato N, Takami T, Nakao K, Matsuura K, Asahina Y, Itoh Y, Tateishi R, Nakamoto Y, Kakazu E, Terai S, Shimizu M, Ueno Y, Akuta N, Miyazaki M, Nozaki Y, Kabayama M, Sobue S, Moriuchi A, Miyaki T, Kodama T, Tatsumi T, Yamada T, Takehara T.
    J Gastroenterol. 2023 Oct 13. doi: 10.1007/s00535-023-02039-x.